190 related articles for article (PubMed ID: 30733479)
21. Three-dimensional quantitative structure-activity relationship (QSAR) and receptor mapping of cytochrome P-450(14 alpha DM) inhibiting azole antifungal agents.
Talele TT; Kulkarni VM
J Chem Inf Comput Sci; 1999; 39(2):204-10. PubMed ID: 10192939
[TBL] [Abstract][Full Text] [Related]
22. Modulation of the interaction between human P450 3A4 and B. megaterium reductase via engineered loops.
Castrignanò S; D'Avino S; Di Nardo G; Catucci G; Sadeghi SJ; Gilardi G
Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):116-125. PubMed ID: 28734977
[TBL] [Abstract][Full Text] [Related]
23. Effects of Y132H and F145L substitutions on the activity, azole resistance and spectral properties of Candida albicans sterol 14-demethylase P450 (CYP51): a live example showing the selection of altered P450 through interaction with environmental compounds.
Kudo M; Ohi M; Aoyama Y; Nitahara Y; Chung SK; Yoshida Y
J Biochem; 2005 May; 137(5):625-32. PubMed ID: 15944416
[TBL] [Abstract][Full Text] [Related]
24. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
25. An Enzymatic Route to α-Tocopherol Synthons: Aromatic Hydroxylation of Pseudocumene and Mesitylene with P450 BM3.
Dennig A; Weingartner AM; Kardashliev T; Müller CA; Tassano E; Schürmann M; Ruff AJ; Schwaneberg U
Chemistry; 2017 Dec; 23(71):17981-17991. PubMed ID: 28990705
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Antifungal Azole Interactions with Adult Cytochrome P450 3A4 versus Neonatal Cytochrome P450 3A7.
Godamudunage MP; Grech AM; Scott EE
Drug Metab Dispos; 2018 Sep; 46(9):1329-1337. PubMed ID: 29991575
[TBL] [Abstract][Full Text] [Related]
27. Production of hydroxlated flavonoids with cytochrome P450 BM3 variant F87V and their antioxidative activities.
Kitamura E; Otomatsu T; Maeda C; Aoki Y; Ota C; Misawa N; Shindo K
Biosci Biotechnol Biochem; 2013; 77(6):1340-3. PubMed ID: 23748780
[TBL] [Abstract][Full Text] [Related]
28. New azoles with potent antifungal activity: design, synthesis and molecular docking.
Che X; Sheng C; Wang W; Cao Y; Xu Y; Ji H; Dong G; Miao Z; Yao J; Zhang W
Eur J Med Chem; 2009 Oct; 44(10):4218-26. PubMed ID: 19539408
[TBL] [Abstract][Full Text] [Related]
29. Phenylalanine 393 exerts thermodynamic control over the heme of flavocytochrome P450 BM3.
Ost TW; Miles CS; Munro AW; Murdoch J; Reid GA; Chapman SK
Biochemistry; 2001 Nov; 40(45):13421-9. PubMed ID: 11695888
[TBL] [Abstract][Full Text] [Related]
30. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
31. Molecular LEGO by domain-imprinting of cytochrome P450 BM3.
Jetzschmann KJ; Yarman A; Rustam L; Kielb P; Urlacher VB; Fischer A; Weidinger IM; Wollenberger U; Scheller FW
Colloids Surf B Biointerfaces; 2018 Apr; 164():240-246. PubMed ID: 29413602
[TBL] [Abstract][Full Text] [Related]
32. Interaction of nitric oxide with cytochrome P450 BM3.
Quaroni LG; Seward HE; McLean KJ; Girvan HM; Ost TW; Noble MA; Kelly SM; Price NC; Cheesman MR; Smith WE; Munro AW
Biochemistry; 2004 Dec; 43(51):16416-31. PubMed ID: 15610036
[TBL] [Abstract][Full Text] [Related]
33. Insights into electron leakage in the reaction cycle of cytochrome P450 BM3 revealed by kinetic modeling and mutagenesis.
Lim JB; Barker KA; Eller KA; Jiang L; Molina V; Saifee JF; Sikes HD
Protein Sci; 2015 Nov; 24(11):1874-83. PubMed ID: 26311413
[TBL] [Abstract][Full Text] [Related]
34. Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1.
Chenge JT; Duyet LV; Swami S; McLean KJ; Kavanagh ME; Coyne AG; Rigby SE; Cheesman MR; Girvan HM; Levy CW; Rupp B; von Kries JP; Abell C; Leys D; Munro AW
J Biol Chem; 2017 Jan; 292(4):1310-1329. PubMed ID: 27932461
[TBL] [Abstract][Full Text] [Related]
35. A Promiscuous Bacterial P450: The Unparalleled Diversity of BM3 in Pharmaceutical Metabolism.
Thistlethwaite S; Jeffreys LN; Girvan HM; McLean KJ; Munro AW
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768811
[TBL] [Abstract][Full Text] [Related]
36. Insights into an efficient light-driven hybrid P450 BM3 enzyme from crystallographic, spectroscopic and biochemical studies.
Spradlin J; Lee D; Mahadevan S; Mahomed M; Tang L; Lam Q; Colbert A; Shafaat OS; Goodin D; Kloos M; Kato M; Cheruzel LE
Biochim Biophys Acta; 2016 Dec; 1864(12):1732-1738. PubMed ID: 27639964
[TBL] [Abstract][Full Text] [Related]
37. Structure-based rational design, synthesis and antifungal activity of oxime-containing azole derivatives.
Xu Y; Sheng C; Wang W; Che X; Cao Y; Dong G; Wang S; Ji H; Miao Z; Yao J; Zhang W
Bioorg Med Chem Lett; 2010 May; 20(9):2942-5. PubMed ID: 20362444
[TBL] [Abstract][Full Text] [Related]
38. Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking.
Sheng C; Zhang W; Ji H; Zhang M; Song Y; Xu H; Zhu J; Miao Z; Jiang Q; Yao J; Zhou Y; Zhu J; Lü J
J Med Chem; 2006 Apr; 49(8):2512-25. PubMed ID: 16610794
[TBL] [Abstract][Full Text] [Related]
39. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.
Venkataraman H; Verkade-Vreeker MC; Capoferri L; Geerke DP; Vermeulen NP; Commandeur JN
Bioorg Med Chem; 2014 Oct; 22(20):5613-20. PubMed ID: 24999003
[TBL] [Abstract][Full Text] [Related]
40. P450 BM3 crystal structures reveal the role of the charged surface residue Lys/Arg184 in inversion of enantioselective styrene epoxidation.
Shehzad A; Panneerselvam S; Linow M; Bocola M; Roccatano D; Mueller-Dieckmann J; Wilmanns M; Schwaneberg U
Chem Commun (Camb); 2013 May; 49(41):4694-6. PubMed ID: 23589805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
